Cloning, Expression, Purification, and Characterization of Biologically Active Recombinant Hemagglutinin-33, Type A Botulinum Neurotoxin Associated Protein
- 156 Downloads
Botulinum neurotoxin type A, the most toxic substance known to mankind, is produced by Clostridium botulinum type A as a complex with a group of neurotoxin-associated proteins (NAPs) through polycistronic expression of a clustered group of genes. Hemagglutinin-33 (Hn-33) is a 33 kDa subcomponent of NAPs, which is resistant to protease digestion, a feature likely to be involved in the protection of the botulinum neurotoxin from proteolysis. In order to fully understand the function of Hn-33, large amounts of Hn-33 will be needed without dealing with biosafety risks to grow large cultures of C. botulinum. There are difficulties to clone the genes with the high A + T contents produced by C. botulinum. We report here for the first time using the Gateway technology to clone functional Hn-33 that has been expressed in E. coli. The yield of the recombinant Hn-33 was about 12 mg per liter of E. coli culture. The recombinant Hn-33 folds well in aqueous solution as shown with circular dichroism spectra, resists temperature-denaturation, is totally resistant to trypsin proteolysis despite the presence of cleavage sites on the molecular surface, and maintains its biological activities comparable to the native Hn-33 hemagglutination.
KeywordsBotulinum neurotoxin circular dichroism spectroscopy hemagglutination assay hemagglutinin-33 trypsin digestion
This work was supported by a grant from the US Army Medical Research and Material Command under Contract No. DAMD17-02-C-001 and by the National Institutes of Health through New England Center of Excellence for Biodefense (AI057159-01).
- Cai S., Singh B. R. (2001) Biochem. 50:15327–15333Google Scholar
- Inoue K., Fujinaga Y., Honke K., Arimitsu H., Mahmut N., Sakaguchi Y., Ohyama T., Watanabe T., Inoue K., Oguma K. (2001) Microbiology 147:811–819Google Scholar
- Li B., Qian X., Sarkar H. K., Singh B. R. (1998) Biochim. Biophys. Acta 1395:21–27Google Scholar
- Sedlock D. M., Bartus H. F., Zajac I., Actor P. (1981) J. Clin. Microbiol. 13:301–308Google Scholar
- Sharma S. K., Singh B. R. (1998) J. Nat. Toxins. 7:239–253Google Scholar